Bone specific growth factors induce resistance against adjuvant treatment in meningioma cells

Martin Proescholdt, Heinz-Georg Bloß, Eva-Maria Störr, Annette Lohmeier & Alexander Brawanski
Objective: Meningiomas are considered to be benign tumors with slow growth rates and in the majority of cases, complete surgical resection will be curative. However, a certain subset of meningiomas are biologically complex, show a high recurrence rate and a low susceptibility to adjuvant treatment. [for full text, please go to the a.m. URL]